ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Psychiatry

Top Psychiatry Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GERALD FLOREZA

Psychiatry

2,282

$191K

155
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $107

JONATHAN MCMATH MD

Psychiatry

2,254

$169K

116
11 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $107

KEVIN KAVOOKJIAN M.D.

Psychiatry

2,196

$145K

201
32 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $107

LESTER NICHOLSON MD

Psychiatry

2,191

$316K

121
14 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$144
Average prescription price

Avg: $107

DEBORAH RYAN MD

Psychiatry

2,027

$243K

98
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$120
Average prescription price

Avg: $107

ALVIN FINEMAN M.D.

Psychiatry

2,014

$372K

104
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$185
Average prescription price

Avg: $107

JULIE PEASE MD

Psychiatry

1,916

$174K

118
11 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$91
Average prescription price

Avg: $107

EDWARD PONTIUS MD

Psychiatry

1,836

$181K

91
13 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $107

JENNIFER GRAHAM MD

Psychiatry

1,821

$230K

196
12 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $107

KENDRA CORNWALL DO

Psychiatry

1,787

$186K

269
24 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $107

LAURA HANCOCK DO

Psychiatry

1,770

$215K

114
28 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $107

LEORA RABIN MD

Psychiatry

1,660

$185K

89
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $107

KEVIN MCGUIRE M.D.

Psychiatry

1,638

$204K

92
22 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $107

GAIL CLINTON MD

Psychiatry

1,638

$235K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$143
Average prescription price

Avg: $107

WILLIAM GRAPENTINE MD

Psychiatry

1,584

$169K

149
12 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $107

BRYAN WOODS MD

Psychiatry

1,509

$139K

121
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $107

SCOTT TREWORGY MD

Psychiatry

1,504

$150K

154
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $107

THOMAS LANTOS MD

Psychiatry

1,455

$184K

98
17 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $107

REINALDO DE LOS HEROS M.D.

Psychiatry

1,436

$166K

78
0 are 65+

58%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $107

BRIAN QUINT MD

Psychiatry

1,422

$212K

43
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$149
Average prescription price

Avg: $107

HAROLD VAN LONKHUYZEN MD

Psychiatry

1,407

$147K

107
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $107

KAREN OLSON MD

Psychiatry

1,401

$114K

126
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $107

MARJORIE SNYDER MD

Psychiatry

1,388

$156K

113
18 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $107

RONALD BAILYN MD

Psychiatry

1,379

$129K

158
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $107

CHRISTIE EMIGH MD

Psychiatry

1,357

$153K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $107

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank